Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells. - Archive ouverte HAL Access content directly
Journal Articles Cancer Research Year : 2007

Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells.

(1) , (1) , (1) , (1) , (1, 2) , (1) , (1) , (1) , (3) , (1)
1
2
3

Abstract

A unique class of IFN-producing killer dendritic cells (IKDC) resembling natural killer cells has been defined that can recognize and lyse tumor cells through a tumor necrosis factor-related apoptosis-inducing ligand-dependent mechanism. IKDC may mediate the host-dependent antitumor activity of Gleevec/STI571 and other therapeutics that can inhibit the c-kit tyrosine kinase. IKDC represent an important new component of the innate immune system responding to cancer.
Not file

Dates and versions

inserm-00451703 , version 1 (29-01-2010)

Identifiers

Cite

Evelyn Ullrich, Mathieu Bonmort, Grégoire Mignot, Nathalie Chaput, Julien Taieb, et al.. Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells.. Cancer Research, 2007, 67 (3), pp.851-3. ⟨10.1158/0008-5472.CAN-06-3766⟩. ⟨inserm-00451703⟩
131 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More